| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035540 |
| Receipt No. | R000040494 |
| Official scientific title of the study | Resveratrol derivative-rich melinjo seed extract in the treatment of chronic periodontitis patients A randomized controlled pilot study |
| Date of disclosure of the study information | 2019/01/14 |
| Last modified on | 2019/01/14 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Resveratrol derivative-rich melinjo seed extract in the treatment of chronic periodontitis patients
A randomized controlled pilot study |
|
| Title of the study (Brief title) | Resveratrol in the treatment of periodontitis patients | |
| Region |
|
|
| Condition | ||
| Condition | Periodontitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study was to assess the effect of melinjo seed extract on patients who had been treated previously for periodontitis and were in supportive periodontal therapy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The following clinical parameters were recorded at each visit (baseline, week4, week8): (1) pocket depth(PD); (2) clinical attachment level (CAL); (3) bleeding on probing (BOP) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients received 150mg of melinjo seed extract for 8 weeks. | |
| Interventions/Control_2 | Patients received 150mg of placebo for 8 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) no use of systemic antibiotics or oral anti-microbial agents within the past six months; (2) periodontitis defined as the presence (on fully erupted teeth) of at least one site with a probing depth (PD) 5-7 mm; | |||
| Key exclusion criteria | (1)severe systemic disease; (2) pregnancy. | |||
| Target sample size | 18 | |||
| Research contact person | |
| Name of lead principal investigator | Yuichi Izumi |
| Organization | Tokyo Medical and Dental University |
| Division name | Department of Periodontology |
| Address | Yushima 1-5-45 Bunkyo tokyo JAPAN |
| TEL | 03-5803-5488 |
| y-izumi.peri@tmd.ac.jp | |
| Public contact | |
| Name of contact person | Yuichi Ikeda |
| Organization | Tokyo Medical and Dental University |
| Division name | Department of Periodontology |
| Address | Yushima 1-5-45 Bunkyo tokyo JAPAN |
| TEL | 03-5803-5488 |
| Homepage URL | |
| ikeda.peri@tmd.ac.jp | |
| Sponsor | |
| Institute | Tokyo Medical and Dental University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yamada Bee Company, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 1286 |
| Org. issuing International ID_1 | Tokyo Medical and Dental University Institutional Review Board |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | Tokyo Medical and Dental University |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040494 |